Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jun;64(6):2201–2205. doi: 10.1128/iai.64.6.2201-2205.1996

Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis.

R L Cisneros 1, F C Gibson 3rd 1, A O Tzianabos 1
PMCID: PMC174056  PMID: 8675327

Abstract

Previous studies have established the efficacy of soluble polymers of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose (PGG) glucan, a biological-response modifier, in protecting against mortality associated with experimentally induced peritonitis in a rat model. PGG glucan-treated animals showed increases in total leukocyte counts and enhanced bacterial clearance from blood. To further explore the mechanisms) by which this agent confers protection, studies were performed to examine whether protection could be transferred from PGG glucan-treated animals to naive recipients via spleen cells (SC), SC lysates, or serum. Passive-transfer experiments indicated that the responsible factor(s) was transferable by whole SC and SC lysates, as well as by peripheral leukocytes or serum from animals treated with PGG glucan. The transferable factor(s) was resistant to pronase and trypsin digestion, was heat stable at 56 or 80 degrees C, and was not removed by NH4SO4 precipitation. The protective effect of PGG glucan was abrogated by treatment with indomethacin, a potent inhibitor of prostaglandin synthesis. Administration of a purified prostaglandin extract from the sera of PGG glucan-treated animals protected against mortality in the peritonitis model. Furthermore, treatment of rats with exogenous synthetic prostaglandin E2 also conferred protection against mortality. These results suggest that the protective effect exhibited by PGG glucan in the rat peritonitis model is mediated, at least in part, by prostaglandins.

Full Text

The Full Text of this article is available as a PDF (230.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltimore R. S., Kasper D. L., Baker C. J., Goroff D. K. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol. 1977 Feb;118(2):673–678. [PubMed] [Google Scholar]
  2. Castro M., Ralston N. V., Morgenthaler T. I., Rohrbach M. S., Limper A. H. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect Immun. 1994 Aug;62(8):3138–3145. doi: 10.1128/iai.62.8.3138-3145.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Choudhry M. A., Ahmad S., Sayeed M. M. Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis. Infect Immun. 1995 Aug;63(8):3101–3105. doi: 10.1128/iai.63.8.3101-3105.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Czop J. K., Austen K. F. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol. 1985 Apr;134(4):2588–2593. [PubMed] [Google Scholar]
  5. Czop J. K., Austen K. F. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis. Proc Natl Acad Sci U S A. 1985 May;82(9):2751–2755. doi: 10.1073/pnas.82.9.2751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eierman D. F., Yagami M., Erme S. M., Minchey S. R., Harmon P. A., Pratt K. J., Janoff A. S. Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2815–2819. doi: 10.1073/pnas.92.7.2815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Onderdonk A. B., Cisneros R. L., Hinkson P., Ostroff G. Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo. Infect Immun. 1992 Apr;60(4):1642–1647. doi: 10.1128/iai.60.4.1642-1647.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Onderdonk A. B., Markham R. B., Zaleznik D. F., Cisneros R. L., Kasper D. L. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982 Jan;69(1):9–16. doi: 10.1172/JCI110445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Onderdonk A. B., Weinstein W. M., Sullivan N. M., Bartlett J. G., Gorbach S. L. Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun. 1974 Dec;10(6):1256–1259. doi: 10.1128/iai.10.6.1256-1259.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov;20(5):947–957. doi: 10.1016/0090-6980(80)90144-6. [DOI] [PubMed] [Google Scholar]
  11. RIGGI S. J., DI LUZIO N. R. Identification of a reticuloendothelial stimulating agent in zymosan. Am J Physiol. 1961 Feb;200:297–300. doi: 10.1152/ajplegacy.1961.200.2.297. [DOI] [PubMed] [Google Scholar]
  12. Waymack J. P., Guzman R. F., Mason A. D., Jr, Pruitt B. A., Jr Effect of prostaglandin E in multiple experimental models. VII. Effect on resistance to sepsis. Burns. 1990 Feb;16(1):9–12. doi: 10.1016/0305-4179(90)90198-6. [DOI] [PubMed] [Google Scholar]
  13. Weinstein W. M., Onderdonk A. B., Bartlett J. G., Gorbach S. L. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun. 1974 Dec;10(6):1250–1255. doi: 10.1128/iai.10.6.1250-1255.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES